Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Device maker looks to apply fluorescence to skin cancer detection
LED Medical Diagnostics is testing tissue fluorescence technology to identify skin cancer and define surgical margins for the excision of basal cell carcinoma and squamous cell carcinoma. The company's VELscope is already FDA-approved to help determine surgical margins with cancers and precancerous lesions of the mouth.
BioOptics World (3/6)
Or we can send an email on your behalf